Company profile
Profound Medical Corp.
NASDAQ: PROF · Healthcare · Medical - Devices
Canadian filerHQ Mississauga, ONCIK 0001628808Reports USD
#580 of 1,422 Healthcare companies by revenuetop-quartile growth
EA Score
44DFH 57DQ 21GM —SS 58
v0.1 · 55/100 weight · provisional
↑ balance-sheet leverage, Altman-Z · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$18.7M
Rev growth YoY (TTM)
+33.8%
Net income (FY)
-$42.6M
Employees
162
as of 2026-08-13
Market cap
$251.8M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$16.1M$16.1M2025
Net income-$42.6M-$42.6M2025
Operating income-$41.3M-$41.3M2025
Total assets$77.5M$77.5M2025
Liabilities$11.0M$11.0M2025
Equity$66.4M$66.4M2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Recurring - Non-Capital60%
Capital Equipment40%
By geography
UNITED STATES76%
CANADA19%
GERMANY5%
The read
What is Profound Medical Corp.’s revenue?
Profound Medical Corp. booked $16.1M in FY2025 revenue, growing 65% year over year — faster than most Healthcare companies we track, at a -264.4% net margin.
Peers · Healthcare
Seer, Inc.50DStem Holdings, Inc.——FOXO Technologies Inc.41DPatient Portal Technologies, Inc.——Green Growth Brands Inc.——Neuphoria Therapeutics Inc.44DKey facts
CEOArun Swarup Menawat
SectorHealthcare
IndustryMedical - Devices
HeadquartersMississauga, ON
ExchangeNASDAQ: PROF
Employees162
IPO date2019-10-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.